Home › Funds › Avidity Partners Management LP › CGON

Avidity Partners Management LP position in CGON

CG ONCOLOGY INC · Health Care

Avidity Partners Management LP reported holding 1,398,948 shares of CGON (CG ONCOLOGY INC) in its Q2 2026 13F filing — a position valued at US$99.4M, representing 15.92% of its reported portfolio and ranking #2 among its reported holdings. Avidity Partners Management LP has disclosed CGON holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)1.40M sh
Reported value held$99.40M
Portfolio Weight15.92%
First reportedQ1 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Avidity Partners Management LP's CGON position evolved

Avidity Partners Management LP first disclosed a stake in CGON in Q1 2024 at 1,454,765 shares (US$63.9M). The position peaked in Q2 2026 at 1,398,948 shares, worth US$99.4M. Across 10 filings, Avidity Partners Management LP increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,398,948 shares valued at US$99.4M — an increase of 110,000 shares quarter over quarter.. Notable position changes include a 28% increase in Q3 2024 (shares fell 24% over the following quarter), a 34% trim in Q4 2024 (shares fell 15% over the following quarter), a 53% increase in Q2 2025 (shares rose 55% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 1.45M $63.86M New
Q2 2024 1.30M $40.92M Reduce
Q3 2024 1.66M $62.48M Add
Q4 2024 1.10M $31.48M Reduce
Q1 2025 980.94K $24.02M Reduce
Q2 2025 1.50M $39.00M Add
Q3 2025 1.60M $64.48M Add
Q4 2025 1.47M $61.15M Reduce
Q1 2026 1.29M $87.24M Reduce
Q2 2026 1.40M $99.40M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CGON and 13F data

CGON (CG ONCOLOGY INC) is a Health Care company. 52 other funds we track also report a position in CGON — the largest reported positions include RTW INVESTMENTS, LP (US$605.0M), Decheng Capital LLC (US$452.7M), TCG Crossover Management, LLC (US$260.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CGON

All CGON fund holders →

FAQ

How long has Avidity Partners Management LP held CGON?

Avidity Partners Management LP has disclosed CGON holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is Avidity Partners Management LP's current position in CGON?

As of Q2 2026, Avidity Partners Management LP holds 1.40M shares of CGON (CG ONCOLOGY INC), valued at $99.40M, representing 15.92% of its reported portfolio and ranking #2.

Has Avidity Partners Management LP been buying or selling CGON?

In the latest 13F filing (Q2 2026), Avidity Partners Management LP increased its position in CGON. The position peaked in Q2 2026 at 1.40M shares.

Which other funds hold CGON?

Other major institutional holders of CGON include RTW INVESTMENTS, LP, Decheng Capital LLC, TCG Crossover Management, LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.